What is Odne?
Odne, established in 2018, emerged from a significant collaboration between the Swiss Federal Institutes of Technology in Lausanne and Zürich (EPFL & ETH Zürich), licensing cutting-edge technology assets. The company operates at the intersection of Swiss precision and academic innovation, aiming to revolutionize endodontics, the branch of dentistry focused on root canal treatments. Traditionally, endodontic procedures have faced challenges with predictability and success rates, leading to substantial healthcare costs globally. Odne's technology platform is designed to address these critical issues, offering advanced solutions for both dental practitioners and patients. With products slated for launch in 2024, Odne is poised to enhance patient outcomes and transform clinical workflows by tackling complex dental morphologies and improving treatment efficacy.
How much funding has Odne raised?
Odne has raised a total of $5.5M across 1 funding round:
Series A
$5.5M
Series A (2024): $5.5M with participation from Plug & Play, Zürcher Kantonalbank, Revere Partners, and Hatcher
Key Investors in Odne
Plug & Play
Plug & Play is an investor whose involvement suggests a focus on innovative technologies and potentially early-stage ventures, aligning with Odne's high-tech startup profile.
Zürcher Kantonalbank
Zürcher Kantonalbank, a leading Swiss universal bank, provides financial services and likely brings significant capital and banking expertise to Odne's growth phase.
Revere Partners
Revere Partners is a venture capital firm specializing in early-stage oral health innovations, indicating a strategic alignment with Odne's mission to transform endodontics.
What's next for Odne?
With the recent major strategic investment, Odne is well-positioned to advance its product development and prepare for its upcoming market launch in 2024. The enterprise-level backing signifies strong confidence in Odne's innovative technology and its potential to disrupt the global endodontics market. This capital infusion will likely fuel further research and development, scale manufacturing capabilities, and support market entry strategies. The company's focus on improving the success rates of root canal treatments, a procedure performed over 60 million times annually worldwide, indicates a significant market opportunity. Odne's trajectory suggests a move towards scaling operations and establishing a strong foothold in the dental technology sector.
See full Odne company page
